Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community

Ann Intern Med. 2003 Jan 21;138(2):152-3. doi: 10.7326/0003-4819-138-2-200301210-00018.
No abstract available

Publication types

  • Case Reports
  • Editorial
  • Comment

MeSH terms

  • ADAM Proteins
  • ADAMTS13 Protein
  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies / immunology
  • Cyclophosphamide / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Metalloendopeptidases / deficiency
  • Purpura, Thrombotic Thrombocytopenic / drug therapy*
  • Purpura, Thrombotic Thrombocytopenic / immunology
  • Recurrence
  • Rituximab
  • von Willebrand Factor / metabolism

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies
  • Immunosuppressive Agents
  • von Willebrand Factor
  • Rituximab
  • Cyclophosphamide
  • ADAM Proteins
  • Metalloendopeptidases
  • ADAMTS13 Protein
  • ADAMTS13 protein, human